Dogwood Therapeutics
DWTX
9 hedge funds and large institutions have $4.55M invested in Dogwood Therapeutics in 2020 Q4 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
7.74% more ownership
Funds ownership: 0% → 7.74% (+7.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Masters Capital Management
Atlanta,
Georgia
|
+$4.32M |
| 2 |
Jane Street
New York
|
+$918K |
| 3 |
VF
Virtu Financial
New York
|
+$340K |
| 4 |
Millennium Management
New York
|
+$200K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$32.1K |
Top Sellers
DWTX Hedge Fund Activity: Q4 2020 in Review
9 of the 5,677 institutional investors tracked by Wall St. Rank reported a position in Dogwood Therapeutics (DWTX) for Q4 2020, worth a combined $4.55M.
Buyers outnumbered sellers: 9 funds opened new DWTX positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Masters Capital Management, opening a new position worth an estimated $4.32M.
- 9 institutional investors held Dogwood Therapeutics (DWTX) as of Q4 2020, up from 0 in Q3 2020.
- Funds reported $4.55M of Dogwood Therapeutics stock for Q4 2020.
- 9 funds opened new Dogwood Therapeutics positions in Q4 2020 and 0 closed out, a net change of +9 holders.
- The largest Dogwood Therapeutics buyer in Q4 2020 was Masters Capital Management, an estimated $4.32M added.
Based on aggregated 13F filings for Q4 2020.